TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06310239

Intervention type: OTHER
Intervention: Collection of biologic samples and data
Description: * collection of skin flora samples via swabs~* data collection regarding subject's medications See Detailed Description in Study Description section above for more details
Study: NCT06104540

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental I liquid vaseline groups
Description: Patients in the liquid vaseline group will apply liquid vaseline twice a day for 3 months. Depending on the size of the burn area, 5-10 ml of liquid petroleum jelly will be applied to the burn area by massaging for 5 minutes twice a day, and each application will be recorded in the application follow-up form. Patients will be visited on the 15th day, first month, second month, and third month after the application begins.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental II extra virgin olive oil groups
Description: Patients in the extra virgin olive oil group will apply extra virgin olive oil twice a day for 3 months. Depending on the size of the burn area, 5-10 ml of liquid petroleum jelly will be applied to the burn area by massaging for 5 minutes twice a day, and each application will be recorded in the application follow-up form. Patients will be visited on the 15th day, first month, second month, and third month after the application begins.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Croup
Description: No intervention will be made other than the recommendations of the institution's physicians and nurses.
Study: NCT05473884

Intervention type: DEVICE
Intervention: lesion preparation devices
Description: successful recanalization of femoropopliteal artery occlusion and then followed by lesion preparation devices and plain old balloon angioplasty

Intervention type: DEVICE
Intervention: conventional balloon
Description: Lumen gain is achieved by plain old balloon angioplasty under working inflation pressure.
Study: NCT04648709

Intervention type: DIAGNOSTIC_TEST
Intervention: ELISPOT
Description: measure of immune response by ELISPOT
Study: NCT06726889

Intervention type: BEHAVIORAL
Intervention: Reminders
Description: Personalized reminders will be delivered to patients through a common messaging application (WhatsApp)

Intervention type: BEHAVIORAL
Intervention: Feedback
Description: Feedback message will be delivered by physician to patients, through WhatsApp, after medication diary revision

Intervention type: BEHAVIORAL
Intervention: Feedback
Description: Feedback message will be delivered by physician to patients, through WhatsApp, after medication diary revision
Study: NCT04648709

Intervention type: DIAGNOSTIC_TEST
Intervention: ELISPOT
Description: measure of immune response by ELISPOT

Intervention type: DIAGNOSTIC_TEST
Intervention: ELISPOT
Description: measure of immune response by ELISPOT

Intervention type: DIAGNOSTIC_TEST
Intervention: ELISPOT
Description: measure of immune response by ELISPOT

Intervention type: DIAGNOSTIC_TEST
Intervention: ELISPOT
Description: measure of immune response by ELISPOT

Intervention type: DIAGNOSTIC_TEST
Intervention: QUANTIFERON
Description: measure of immune response by QUANTIFERON

Intervention type: DIAGNOSTIC_TEST
Intervention: QUANTIFERON
Description: measure of immune response by QUANTIFERON

Intervention type: DIAGNOSTIC_TEST
Intervention: QUANTIFERON
Description: measure of immune response by QUANTIFERON

Intervention type: DIAGNOSTIC_TEST
Intervention: QUANTIFERON
Description: measure of immune response by QUANTIFERON

Intervention type: DIAGNOSTIC_TEST
Intervention: QUANTIFERON
Description: measure of immune response by QUANTIFERON
Study: NCT05220800

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron(III)isomaltoside
Description: Weight-dependent dosage of iron(III)isomaltoside. See group descriptions

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Isoton saline infusion
Study: NCT06643611

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitor
Description: Patient will be provided a continuous glucose monitor. Pharmacist will provide information regarding how to best manage type 2 diabetes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Routine physician office visits and hemoglobinA1c every 3 for those with HbA1c outside goal and every 6 months for those with HbA1c within goal. Medication regimens managed by physicians, nurse practitioners, and physician assistants. Patients are sent reminders on the phone prior to their visits or when they are due for a visit or any physical examination.
Study: NCT06645132

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise intervention
Description: Exercise intervention leveraging wearable devices and a custom smartphone application to cue exercise as a reminder during idle time during an inpatient hospital stay, post allogenic bone marrow transplant.
Study: NCT05456919

Intervention type: OTHER
Intervention: SFQ28 Questionnaire
Description: SFQ28 Questionnaire

Intervention type: OTHER
Intervention: SFQ28 Questionnaire
Description: SFQ28 Questionnaire

Intervention type: OTHER
Intervention: SFQ28 Questionnaire
Description: SFQ28 Questionnaire

Intervention type: OTHER
Intervention: SFQ28 Questionnaire
Description: SFQ28 Questionnaire
Study: NCT05506644

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HRV-Biofeedback/Mind-Body Therapy
Description: A 7-week protocol using real-time feedback on heart rate variability
Study: NCT05877404

Intervention type: OTHER
Intervention: Surveys
Description: Survey on practice patterns surrounding tumor genetic testing in endometrial cancer.
Study: NCT05557019

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Booster Balloon Catheter
Description: The Booster balloon therapy (i.e. partial occlusion of the CS lumen with a subsequent backward pressure elevation without obstructing the CS blood flow) will start immediately after a successful PCI of the culprit coronary lesion in the LAD, with TIMI-II flow restoration. The Booster balloon therapy will then be continued for up to 90 min, but not less than 60 min.
Study: NCT05969561

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound-guided femoral nerve block
Description: The local analgesia is injected and infiltrated around the femoral nerve under ultrasound guidance.

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Intravenous or intramuscular pain medication
Description: Intravenous or intramuscular pain medication is given for patients with hip fracture.
Study: NCT04639206

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HOBSCOTCH
Description: HOBSCOTCH (Home Based Self-management and Cognitive Training Changes lives) is a home-based self-management program to treat cognitive symptoms and improve quality of life while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life. The HOBSCOTCH intervention consists of 8 weekly sessions conducted in-person, over the telephone, or via video-conferencing. A smart phone application will be used to collect data on seizure frequency, medication adherence, and patient engagement.
Study: NCT05838560

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib + quercetin
Description: dasatinib 100mg / quercetin 1250mg The intervention will involve the participant taking both dasatinib and quercetin combined.
Study: NCT05120869

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored HPV Education and Professional Skills Intervention Group
Description: The provider education and professional skills intervention will involve audio and visual content and will be delivered in the English language.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General HPV Education and Communication Skills Control Group
Description: The general provider education intervention will involve audio and visual content and will be delivered in the English language.
Study: NCT06391203

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Long-term Drainage
Description: After drilling or puncture, the drainage catheter is indwelling continuously and keeps to drainage for 7 days. Keep incision sterility, record the daily fluid drainage flow, and perform biochemical and bacterial culture identification tests for CSF regularly. Removing drainage catheter when the allocated time is reached. If there is still unabsorbed effusion after the allocated time is reached, the catheter placement time is extended and the relevant information is recorded.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Short-term Drainage
Description: After drilling or puncture, the drainage catheter is indwelling continuously and keeps to drainage for 2 days. Keep incision sterility, record the daily fluid drainage flow, and perform biochemical and bacterial culture identification tests for CSF regularly. Removing drainage catheter when the allocated time is reached. If there is still unabsorbed effusion after the allocated time is reached, the catheter placement time is extended and the relevant information is recorded.
Study: NCT05952492

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management Skills Training
Description: Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include stress management skills training and health education content.
Study: NCT06410287

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ArtSpective
Description: ArtSpective is an interactive, educational program that uses art and museum-based pedagogy. The intervention is delivered asynchronously using a web-based platform. Participants engage with artwork, watch short educational videos, and read short clinical vignettes. After completing the program, participants receive a certificate of completion.

Intervention type: OTHER
Group type: OTHER
Intervention: ArtSpective
Description: ArtSpective is an interactive, educational program that uses art and museum-based pedagogy. The intervention is delivered asynchronously using a web-based platform. Participants engage with artwork, watch short educational videos, and read short clinical vignettes. After completing the program, participants receive a certificate of completion.
Study: NCT05048862

Intervention type: DIAGNOSTIC_TEST
Intervention: Genomics, transcriptome, and proteomics
Description: The DNA, RNA, and protein of the tissues (blood, muscle, nerve and skin) were retrieved and stored in the -80°C refrigerator. The next generation sequencing (whole exon sequencing or whole genome sequencing) and RNA-seq would be performed by NGS \& Microarray Core lab in National Taiwan University or another professional team. The protein analysis would be performed by the Proteomics \& Protein Function Core Lab in National Taiwan University.

Intervention type: DIAGNOSTIC_TEST
Intervention: Genomics, transcriptome, and proteomics
Description: The DNA, RNA, and protein of the tissues (blood, muscle, nerve and skin) were retrieved and stored in the -80°C refrigerator. The next generation sequencing (whole exon sequencing or whole genome sequencing) and RNA-seq would be performed by NGS \& Microarray Core lab in National Taiwan University or another professional team. The protein analysis would be performed by the Proteomics \& Protein Function Core Lab in National Taiwan University.

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory of blood chemical substances, metals and endocrine profiles
Description: The methods of the measurement will follow the standards set by Department of Laboratory Medicine of National Taiwan University Hospital.

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory of blood chemical substances, metals and endocrine profiles
Description: The methods of the measurement will follow the standards set by Department of Laboratory Medicine of National Taiwan University Hospital.
Study: NCT06321757

Intervention type: DEVICE
Intervention: Percutaneous Coronary Intervention with DCB and DAPT
Description: * Patients with PCI (DCB) + standard DAPT standard dual antiplatelet therapy (DAPT)~* Patients with PCI (DCB) + short DAPT
Study: NCT05048862

Intervention type: DIAGNOSTIC_TEST
Intervention: Contact heat evoked potentials
Description: A contact heat evoked potential stimulator (Medoc, Ramat Yishai, Israel) will be used for delivering heat stimulation. Stimuli will be delivered repeatedly to the same stimulation site and the inter-stimulus interval will be randomly set to around 18\~22 s. CHEP will be recorded using a Nicolet Bravo evoked potential system (Nicolet Biomedical, Madison, WI). The recording electrode was placed at the Cz and P3 of international 10-20 system. The impendence of all recording electrodes was kept below 3 kΩ. The evoked potentials were filtered with a bandpass filter at 0.1\~30 Hz. Recording was triggered by the onset of each stimulus, and the sweep time was 1500 ms.
Study: NCT04685590

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib + Quercetin
Description: D+Q will be administered once daily (1st dose of each cycle will be given, supervised, at the clinic visit; the 2nd dose will be taken at home) for 2 consecutive days followed by a 13-day (+/- 2 day) no-drug period for 12 consecutive weeks for 6 rounds of administration.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Capsules
Description: Matching placebo capsules following the same administration protocol as the experimental treatment - administered once daily (1st dose of each cycle will be given, supervised, at the clinic visit; the 2nd dose will be taken at home) for 2 consecutive days followed by a 13-day (+/- 2 day) no-drug period for 12 consecutive weeks for 6 rounds of administration.
Study: NCT05809622

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Elbow focused rehabilitation
Description: * Patient education~* Activity modification~* 2 days/week, 8 weeks in total~* Exercises for the wrist extensor tendon, especially the extensor carpi radialis brevis (EKRB) (stretching + strengthening)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scapular and rotator cuff muscles strengthening
Description: * Patient education~* Activity modification~* 2 days/week, 8 weeks in total~* Exercises for the wrist extensor tendon, especially the extensor carpi radialis brevis (EKRB) (stretching + strengthening)~* Scapular stabilizer muscle + rotator cuff (RM) strengthening
Study: NCT04218708

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine patch and gum
Description: Nicotine patch and gum will be given to subjects in the Nicotine replacement therapy cohort every visit after providing exhaled CO/Saliva cotinine test.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Minnesota Nicotine Withdrawal Scale (MNWS)
Description: The MNWS assesses symptoms associated with nicotine withdrawal (i.e., craving, irritability, anxiety, difficulty concentrating, restlessness, increased appetite or weight gain, depression, and insomnia).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Minnesota Nicotine Withdrawal Scale (MNWS)
Description: The MNWS assesses symptoms associated with nicotine withdrawal (i.e., craving, irritability, anxiety, difficulty concentrating, restlessness, increased appetite or weight gain, depression, and insomnia).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ASSIST (the Alcohol, Smoking and Substance Involvement Screening)
Description: The ASSIST is the Alcohol, Smoking and Substance Involvement Screening Test. It is a brief screening questionnaire to find out about people's use of psychoactive substances (alcohol, smoking and substance involvement).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ASSIST (the Alcohol, Smoking and Substance Involvement Screening)
Description: The ASSIST is the Alcohol, Smoking and Substance Involvement Screening Test. It is a brief screening questionnaire to find out about people's use of psychoactive substances (alcohol, smoking and substance involvement).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: At each study visit, participants will receive counseling protocol that will be based on effective counseling manuals. The PI will train the research assistant who will assist the PI in tailoring the manual to the target group: counseling will cover health education, social support issues, and motivational enhancement to improve self-efficacy while addressing other aspects known to contribute to smoking among PLWHA (e.g., tips on dealing with depression and feeling stigmatized particularly in relation to HIV).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: At each study visit, participants will receive counseling protocol that will be based on effective counseling manuals. The PI will train the research assistant who will assist the PI in tailoring the manual to the target group: counseling will cover health education, social support issues, and motivational enhancement to improve self-efficacy while addressing other aspects known to contribute to smoking among PLWHA (e.g., tips on dealing with depression and feeling stigmatized particularly in relation to HIV).
Study: NCT06726889

Intervention type: BEHAVIORAL
Intervention: Feedback
Description: Feedback message will be delivered by physician to patients, through WhatsApp, after medication diary revision

Intervention type: BEHAVIORAL
Intervention: Feedback
Description: Feedback message will be delivered by physician to patients, through WhatsApp, after medication diary revision
Study: NCT06743529

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: immediate empiric Antibiotic Therapy (started within 1 hour after randomization) with antibiotic(s) chosen by the bedside physician based on time of ventilator-associated pneumoniaoccurrence, risk of antimicrobial resistance, local ecology, and local protocol. If the respiratory samples are negative, Antibiotic Therapy will be stopped. If ventilator-associated pneumonia is confirmed by positive samples, Antibiotic Therapy active against the recovered bacterial specie(s) will be given for a total of 7 days.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conservative strategy
Description: No Antibiotic Therapy until receipt of the respiratory sample culture and/or polymerase chain reaction results. If these results are negative, no Antibiotic Therapy is given. If they are positive (confirmed ventilator-associated pneumonia), Antibiotic Therapy is started as appropriate for the bacterial specie(s) detected by culture and/or polymerase chain reaction, without considering gram-stain results and without waiting for antimicrobial susceptibility testing results, and continued for a total of 7 days of Antibiotic Therapy active against the identified bacterial specie(s).
Study: NCT06738472

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: home based exercises
Description: given exercises to the participants
Study: NCT06748053

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK5784283
Description: GSK5784283 will be administered.
Study: NCT04218708

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NIDA Standardized Research E-cigarettes (SREC)
Description: NIDA SREC has a case with a liquid tank. The e-liquid is supplied in sealed disposable cartridges that deliver \>300 puffs / cartridge. The SREC uses a battery recharged via a micro USB port. A single charge is designed to outlast the capacity of an e-liquid cartridge. The e-liquid is tobacco flavored and contains nicotine.
Study: NCT05069558

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational PFO Closure Device
Description: Occlutech Flex II PFO Closure Device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care PFO Closure Device
Description: Amplatzer PFO Occluder and Gore Cardioform PFO Occluder
Study: NCT06074536

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: patient-centered approach training
Description: face to face training of general practitioner of interventional arm
Study: NCT05388760

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tralokinumab
Description: A loading dose under the skin (s.c.) at first treatment visit and then injections in accordance with a pre-defined schedule for 16 weeks (initial treatment) followed by a maintenance treatment for 52 weeks (open-label treatment) and a long-term extension treatment period for up to 106 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tralokinumab
Description: A loading dose under the skin (s.c.) at first treatment visit and then injections in accordance with a pre-defined schedule for 16 weeks (initial treatment) followed by a maintenance treatment for 52 weeks (open-label treatment) and a long-term extension treatment period for up to 106 weeks.
Study: NCT06105684

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine Pill
Description: Will be given once per day by mouth
Study: NCT00775476

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-acetylcysteine
Description: Capsules of NAC, each containing 600 mg of NAC between dosages of 2.4 g to 4.8 g daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo (sugar) twice daily, daily dosage will match that of NAC that was tolerated between daily dosages of 2.4 g and 4.8 g during the open-label titration phase.